Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last SFr.1.41 CHF
Change Today -0.08 / -5.37%
Volume 2.1M
As of 11:43 AM 09/1/15 All times are local (Market data is delayed by at least 15 minutes).
text size: T | T
Back to Snapshot
Company Description

Contact Info

Duggingerstrasse 23

Reinach, 4153

Switzerland

Phone: 41 61 485 2000

Fax:

Evolva Holding SA, a biosynthetic company, discovers, develops, manufactures, and commercializes ingredients for nutrition, health care, and wellness products in Switzerland and internationally. The company’s principal products include Resveratrol, a natural compound produced in grapes and other plants as a response against environmental stress factors; Vanillin, a complex blend of compounds extracted from the seed pods of the vanilla orchid; and Stevia, a natural, zero-calorie food, and beverage sweetener derived from Stevia rebaudiana, a leafy green plant for family. It also offers Nootkatone, a citrus ingredient associated with grapefruits, which is used as a flavor and fragrance ingredient; and as agent against a range of insect pests, including ticks, bed bugs, and mosquitoes. In addition, the company provides Agarwood for perfume makers and traditional medicine practitioners; Saffron, a spice made by yeast fermentation; Valencene, an orange flavor and fragrance ingredient used in food and drink, personal care, and household products, as well as an intermediate to produce nootkatone; and Sandalwood, an oil used in preparing various types of perfume compositions. Further, it offers legacy products, such as EV-077, a compound for diabetic nephropathy and other diabetic complications; EV-35, a preclinical antibiotic; and Pomecins, an antifungal ingredient that prevent mould and yeast growth. The company is based in Reinach, Switzerland.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
EVE:SW SFr.1.41 CHF -0.08

EVE Competitors

Market data is delayed at least 15 minutes.

Company Last Change
GLG Life Tech Corp C$0.30 CAD -0.04
Ingredion Inc $84.06 USD -2.28
PureCircle Ltd 400.00 GBp 0.00
Stevia First Corp $0.18 USD +0.02
View Industry Companies
 

Industry Analysis

EVE

Industry Average

Valuation EVE Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 42.4x
Price/Book 2.9x
Price/Cash Flow NM Not Meaningful
TEV/Sales 41.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EVOLVA HOLDING SA, please visit www.evolva.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.